AmCad BioMed Overview
Get informed when a big investor buys or sells
+ Follow333.56
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for 4188.TWO is 333.56. That is above the sector sector average of 9.98. Investors often review this figure alongside AmCad BioMed's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, 4188.TWO currently prints 333.56 for PEG ratio, while the sector average sits near 9.98. That is roughly 3241.3% above the sector mean. Large gaps often invite a closer look at AmCad BioMed's growth, margins, and balance sheet.
A PEG ratio of 333.56 for AmCad BioMed is not 'good' or 'bad' on its own. Compare it with the peer average (9.98) and with 4188.TWO's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting 4188.TWO's PEG ratio (333.56), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
